These in vitro findings might explain the beneficial effects of inhibiting JNK or MMP-2 in chronically inflamed lacrimal glands of Sjogren’s syndrome dry eye disease animal models, resulting in increased tear production (22, 30). This evidence concerns the gene MAPK8 and Sjogren syndrome.